1985
DOI: 10.1016/s0378-4347(00)84058-x
|View full text |Cite
|
Sign up to set email alerts
|

Simple high-performance liquid chromatographic method for the determination of medroxyprogesterone acetate in human plasma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

1989
1989
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 5 publications
0
4
0
Order By: Relevance
“…Numerous recent researches for this analysis have been reported concerning the method sensitivity and selectivity in association with various instruments including GC, HPLC and others [6][7][8][9][10][11][12][13][14][15]. However, each of which had their advantages and disadvantages.…”
Section: Determination Of Mpa In Hormonal Contraceptive Drugsmentioning
confidence: 99%
See 1 more Smart Citation
“…Numerous recent researches for this analysis have been reported concerning the method sensitivity and selectivity in association with various instruments including GC, HPLC and others [6][7][8][9][10][11][12][13][14][15]. However, each of which had their advantages and disadvantages.…”
Section: Determination Of Mpa In Hormonal Contraceptive Drugsmentioning
confidence: 99%
“…Attempts have been made to optimize the methods for MPA analysis using small amounts of plasma samples [7,8]. Quantitative analysis of MPA in plasma by HPLC with ultraviolet (UV) detection was also carried out, but did not give satisfactory detection limit [9,10]. The high sensitivity of the GC-MS has also been used to monitor the MPA level in human serum [11].…”
Section: Determination Of Mpa In Hormonal Contraceptive Drugsmentioning
confidence: 99%
“…Up to now, several methods including spectrophotometry [4,5], HPLC [6][7][8][9], LC-MS [10][11][12][13][14][15][16], GC-MS [16][17][18][19][20] and immunoassay [21] have been published for determining MPA in pharmaceutical preparations and biological fluids. Two stabilityindicating HPLC methods for MPA tablet formulations have been reported.…”
Section: Introductionmentioning
confidence: 99%
“…2,3 The combination estrogen-gestagen is used for the treatment of estrogenic deficiency syndrome to control its symptoms (climateric syndrome), such as loss of bone minerals and development of heart disease. 4 Up to now, various analytical methods for the determination of EV or MPA have been reported including voltammetry, 1 spectrophotometry, 5,6 fluorometry, 7 high performance liquid chromatography (HPLC), 4,[8][9][10][11] gas chromatography-mass spectrometry (GC-MS), [12][13][14] FT-Raman spectroscopy 15 and chemiluminescence enzyme immunoassay 16 in pharmaceutical preparations and biological liquids. But there has been no GC-MS method reported in the litearature for simultaneous determination of these two hormones in pharmaceutical preparations.…”
mentioning
confidence: 99%